ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Feb 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-02-06

Reporting Person: FRYKMAN EDWARD W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-06	Common Stock	A	15000	—	Acquired	22000	Direct
2014-02-07	Common Stock	M	5000	$10.00	Acquired	27000	Direct
2014-02-07	Common Stock	S	3148	$15.9771	Disposed	23852	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-07	Stock Option	$10.00	M	5000	Disposed	2014-02-15	Common Stock (5000)	Direct

Footnotes

F1: Represents shares underlying restricted stock unit, which shares will vest on the one year anniversary of the date of grant.

F2: Not applicable.

F3: Shares sold to cover exercise price of stock option.

F4: Includes shares underlying other options previously granted.